中国医院用药评价与分析2016，Vol.16Issue(6)：850-852,853,4.DOI:10.14009/j.issn.1672-2124.2016.06.047
临床药师参与弥漫大B细胞淋巴瘤患者抗乙型肝炎病毒治疗的药学实践
Pharmaceutical Care for Patients with Diffuse Large B-Cell Lymphoma in Anti-hepatitis B Virus Therapy by Clinical Pharmacists
蒙光义 1黄立峰 2陈万生 1彭评志 1庞家莲3
作者信息
- 1. 上海长征医院药学部，上海 200003
- 2. 玉林市第一人民医院药学部，广西玉林 537000
- 3. 玉林市第一人民医院药学部，广西玉林 537000
- 折叠
摘要
Abstract
OBJECTIVE:To investigate the drug selection and pharmaceutical care for patients with diffuse large B -cell lymphoma in anti-hepatitis B virus ( HBV) therapy .METHODS:The clinical pharmacists participated and evaluated the treatment process of anti-HBV therapy in diffuse large B-cell lymphoma patient .By referring to the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology:Non-hodgkin Lymphoma and Expert Consensus of Special Antiviral Treatment in Patients with Chronic Hepatitis B:2014 and the related literatures , the clinical pharmacists formulated rational anti-HBV medication regimens .RESULTS: Combined with the patients ’practical conditions , the clinical pharmacists advised the clinicians to use Entecavir tablets as anti -HBV medication and provided pharmaceutical care for patients according to the guidelines and expert consensus , so as to avoid HBV reactivation and explosive hepatitis B and promote the smooth completion of chemotherapy .CONCLUSIONS: The clinical pharmacists must pay more attention to the motoring of HBV in patients with diffuse large B-cell lymphoma , choose correct and rational anti-HBV to promote the smooth completion of chemotherapy , so as to ensure the safe and effective medication .关键词
弥漫大B细胞淋巴瘤/乙型肝炎病毒/临床药师/药学监护Key words
Diffuse large B-cell lymphoma/Hepatitis B virus/Clinical pharmacists/Pharmaceutical care分类
医药卫生引用本文复制引用
蒙光义,黄立峰,陈万生,彭评志,庞家莲..临床药师参与弥漫大B细胞淋巴瘤患者抗乙型肝炎病毒治疗的药学实践[J].中国医院用药评价与分析,2016,16(6):850-852,853,4.
